Sometimes research confirms the zeitgeist and sometimes it’s way ahead of the zeitgeist. An example of the latter is this amazingly prescient 2018 paper published in the journal @JAMACardiology by @kevin_volpp, @hmkyale, and David Asch. Kevin Volpp, the director of the @Penn Center for Health Incentives and Behavioral Economics at the University of Pennsylvania, and David Asch, both Professors of Medicine and Health Care Management at the School of Medicine and @Wharton School at the University of Pennsylvania, are members of @Thrive Global’s scientific advisory board.
The paper, entitled “Mass Customization for Population Health,” notes that the U.S., which lags in life expectancy compared to other industrialized countries, spends huge amounts of money developing new medical technologies and yet doesn’t deploy existing ones very well. In cases in which effective treatment options exist, adherence is only about 40% to 45%.
And here was the prescient part: to increase adherence, and thus better health outcomes, “risk reduction strategies might be matched to individual preferences, observed behavioral phenotypes, and estimated risk.”
That’s exactly what AI, through hyper-personalization, will allow us to do — and it’s also what we’re currently integrating into our behavior change model at Thrive. Imagine a customized, hyper-personalized AI health coach trained not only on the best peer-reviewed science, but also on our biometric, lab and other medical data, and, as the paper states, our individual preferences — what conditions allow us to get quality sleep, which foods we love and don’t love, how and when we’re most likely to walk, move and stretch, and the most effective ways we can reduce stress.
The combination of behavioral science engagement tools combined with synchronized and automated medication refills could be thought of, the authors write, as a “behavioral polypill.” As they conclude, “behaviors ultimately determine much of the effectiveness we derive from the treatment strategies we already have.”
With AI, the behavioral polypill can become a powerful reality and significantly move the needle on health outcomes. jamanetwork.com/journals/jamacardiology/article-abstract/…